Vacci-nation: A case study in health and prosperity

Article

Vaccines have been integral to health and prosperity in the last three centuries.

The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.

Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.

On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.

Related items

  1. A stack of large shipping containers painted with the UK and EU flags

    Aligning for growth? The benefits of an EU-UK mutual recognition agreement

    Scoping the potential next frontier of a deepening relationship between the UK and the EU.
  2. A wind turbine stands in the middle of a field of solar panels on a sunny day

    The wiring behind rewiring the state: Energy devolution in England

    How the government can give local leaders the opportunities to lead energy transformation locally.
  3. Aerial views of Manchester skyline of new skyscrapers

    Devolution that delivers: Fiscal power for regional growth

    The UK is one of the most centralised countries in the developed world, and one of the most regionally unequal.